Foghorn Therapeutics Inc. (FHTX) Moves 22.7% Higher: Will This Strength Last?

Foghorn Therapeutics Inc. (FHTX) shares ended the last trading session 22.7% higher at $5.95. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11.3% loss over the past four weeks.The sudden gain in the stock price can be attributed to the positive investor mindset regarding the company's pipeline. Last week, Foghorn announced that its pre-clinical candidate, FHD-909, has been selected by Eli Lilly for clinical devel ...